Bill > SRes266

This resolution designates May 2025 as "ALS Awareness Month" and provides a comprehensive overview of Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. The resolution highlights critical information about ALS, including its impact: the disease typically results in a life expectancy of 2-5 years after diagnosis, affects approximately 5,000 new individuals annually in the United States, and occurs across all demographics without racial, ethnic, gender, or socioeconomic boundaries. The resolution emphasizes that the cause remains unknown in 90% of cases, and the disease progressively weakens muscles, leading to potential paralysis of limbs and vital functions like breathing. The Senate resolves to support individuals with ALS by ensuring access to treatments and services, identifying risk factors, empowering patients to maintain independence, and reducing the disease's physical and emotional burdens. Additionally, the resolution commends the dedication of family members, researchers, caregivers, and volunteers working to improve ALS patients' quality of life and develop potential treatments and cures.

https://www.congress.gov/bill/119th-congress/senate-resolution/266/all-info